Genes involved in mitochondrial biogenesis/function are induced in response to bilio-pancreatic diversion in morbidly obese individuals with normal glucose tolerance but not in type 2 diabetic patients

[1]  Joris Hoeks,et al.  Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients , 2008, Diabetes.

[2]  R. Hoffman.  Indices of insulin action calculated from fasting glucose and insulin reflect hepatic, not peripheral, insulin sensitivity in African‐American and Caucasian adolescents , 2008, Pediatric diabetes.

[3]  Y. Asmann,et al.  Asian Indians Have Enhanced Skeletal Muscle Mitochondrial Capacity to Produce ATP in Association With Severe Insulin Resistance , 2008, Diabetes.

[4]  N. M. van den Broek,et al.  Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. , 2008, European journal of endocrinology.

[5]  F. Toledo,et al.  Mitochondrial Capacity in Skeletal Muscle Is Not Stimulated by Weight Loss Despite Increases in Insulin Action and Decreases in Intramyocellular Lipid Content , 2008, Diabetes.

[6]  A. Russell,et al.  Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure , 2007, Diabetologia.

[7]  K. Sahlin,et al.  Mitochondrial Respiration Is Decreased in Skeletal Muscle of Patients With Type 2 Diabetes , 2007, Diabetes.

[8]  P. Puigserver,et al.  Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC‐1α , 2007, The EMBO journal.

[9]  R. Boushel,et al.  Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle , 2007, Diabetologia.

[10]  A. Mari,et al.  Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery , 2006, Diabetes.

[11]  M. Palacín,et al.  Evidence for a Mitochondrial Regulatory Pathway Defined by Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α, Estrogen-Related Receptor-α, and Mitofusin 2 , 2006, Diabetes.

[12]  K. Petersen,et al.  Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. , 2005, The Journal of clinical investigation.

[13]  A. Zorzano,et al.  Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? , 2005, Diabetologia.

[14]  Marco Castagneto,et al.  Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. , 2005, Diabetes.

[15]  E. Ferrannini,et al.  Leptin pulsatility in formerly obese women , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  M. Palacín,et al.  The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. , 2005, Human molecular genetics.

[17]  H. Vidal,et al.  Changes in fat mass influence SREBP-1c and UCP-2 gene expression in formerly obese subjects. , 2005, Obesity research.

[18]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[19]  G. Mingrone,et al.  VO2, VCO2, and RQ in a respiratory chamber: accurate estimation based on a new mathematical model using the Kalman-Bucy method. , 2004, Journal of applied physiology.

[20]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[21]  H. Vidal,et al.  Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity. , 2003, Atherosclerosis.

[22]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[23]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Douglas L. Rothman,et al.  Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance , 2003, Science.

[25]  J. Zierath,et al.  Mitofusin-2 Determines Mitochondrial Network Architecture and Mitochondrial Metabolism , 2003, The Journal of Biological Chemistry.

[26]  P. Schrauwen,et al.  Decreased uncoupling protein expression and intramyocytic triglyceride depletion in formerly obese subjects. , 2003, Obesity research.

[27]  R. Ross.  Does exercise without weight loss improve insulin sensitivity? , 2003, Diabetes care.

[28]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[29]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[30]  J. Simoneau,et al.  Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  P. Puigserver,et al.  A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis , 1998, Cell.

[32]  R. Tacchino,et al.  Normalization of Insulin Sensitivity in the Obese Patient after Stable Weight Reduction with Bilio-Pancreatic Diversion , 1994, Obesity surgery.

[33]  N. Ruderman,et al.  Ten-Year Experience with an Exercise-Based Outpatient Life-Style Modification Program in the Treatment of Diabetes Mellitus , 1992, Diabetes Care.

[34]  J. Lancaster,et al.  Total Body Fat Content and Fat Topography Are Associated Differently With In Vivo Glucose Metabolism in Nonobese and Obese Nondiabetic Women , 1992, Diabetes.

[35]  E. Ferrannini.  The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.

[36]  N. Scopinaro,et al.  Bilio‐pancreatic bypass for obesity: II. Initial experience in man , 1979, The British journal of surgery.

[37]  J. Holloszy.  Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. , 2009, The American journal of clinical nutrition.

[38]  M. Palacín,et al.  Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha, and mitofusin 2. , 2006, Diabetes.

[39]  B. Goodpaster,et al.  Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. , 2005, Diabetes.

[40]  Steven P Gygi,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. , 2005, Nature.

[41]  Y. Boirie,et al.  Expression of Mfn 2 , the Charcot-Marie-Tooth Neuropathy Type 2 A Gene , in Human Skeletal Muscle Effects of Type 2 Diabetes , Obesity , Weight Loss , and the Regulatory Role of Tumor Necrosis Factor and Interleukin-6 , 2005 .

[42]  Roberto Vettor,et al.  Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. , 2002, Diabetes.

[43]  M. Brennan,et al.  Total body water and the exchangeable hydrogen. II. A review of comparative data from animals based on isotope dilution and desiccation, with a report of new data from the rat. , 1977, The American journal of physiology.